Publication | Closed Access

ABT-450/r/Ombitasvir plus Dasabuvir With or Without Ribavirin in HCV Genotype 1-infected Patients Receiving Stable Opioid Substitution Treatment: Pooled Analysis of Efficacy and Safety in Phase 2 and Phase 3 Trials

Treatment And PreventionViral HepatitisAntiviral Drug DevelopmentAntiviral TherapyHepatitisVirologyPharmacotherapyAntiviral DrugPhase 2MedicinePhase 3